Skip to main content
Premium Trial:

Request an Annual Quote

Sterner Stuff

A new bill introduced by US Congressman Edward Markey (D-Mass.) to the House of Representatives calls for tougher reporting requirements to ClinicalTrials.gov, says Peter Mansell at PharmaTimes. The proposed legislation, called the Trial and Experimental Studies Transparency, or TEST, Act of 2012, would require that results from all clinical trials be posted to the database within a year of the trial's end. Additionally, it says that trials would need to be registered prior to enrolling any participants and that the National Institutes of Health and the Food and Drug Administration have to report to Congress on new database standards. Mansell adds that the bill also calls for sponsors of trials conducted outside the US, but that plan to market in the US, to also have to register with and report to the database.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.